Ethanol, percutaneous injection

Okada, S., Aoki, K., Okazaki, N., Nose, H., Yoshimori, M., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Takayasu, K., Moriyama, N. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report. Hepato-... [Pg.518]

Bartolozzi, C., Lencioni, R., Ricci, P., Paolicchl, A., Rossi, P., Passa-riello, R. Hepatocellular carcinoma treatment with percutaneous ethanol injection evaluation with contrast-enhanced color Doppler US. Radiology 1998 209 387- 393... [Pg.802]

Koda, M., Murawaki, Y., Mitsuda, A., Ohyama, K., Horie, Y., Suou, T., Kawasaki, H., Ikawa, S. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000 88 529-537... [Pg.804]

Hepatocellular carcinoma and cirrhosis in 746 patients long-term residts of percutaneous ethanol injection. Radiology 1995 197 101-108... [Pg.804]

Mazzanti, R., Arena, U., Pantaleo, P., Antonuzzo, L., Cipriani, G., Neri, B., Giordano, C., Lanini, F., Marchetti, S., Gentilini, P. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection A 10-year experience. Can. J. Gastroenterol. 2004 18 611—618... [Pg.804]

Pompili, M., Rapacdni, G.L., de Luca, F., Caturelll, E., Astone, A., Siena, D.A., Villanl, M.R., Grattagliano, A., Cedrone, A., Gasbarrini, G. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. Cancer 1997 79 1501-1508... [Pg.805]

There have been three studies of the effects of percutaneous ethanol injections in the treatment of hepatocellular carcinoma, either alone (12,13) or in combination with transcatheter arterial embolization (14). The procedure was effective and safe and improved long-term survival. Adverse effects were generally mild and of short duration, and commonly included abdominal pain, fever, intoxication (especially among non-drinkers), transient rises in serum transaminases, and chemical thrombosis of the tributary branch of the portal vein. Hepatic infarction has been reported in two patients with hepatocellular carcinoma after percutaneous ethanol injection of the tumors (15). Both patients had previously been treated with transcatheter arterial infusion using a suspension of styrene maleic acid neocarzinostatin, and the liver damage may have occurred through a combination of arterial damage due to the neocarzinostatin and vasculitis caused by flow of the injected ethanol into a portal vein branch. [Pg.1286]

In an open trial, percutaneous ethanol injections into the liver improved prognosis compared with conservative treatment in 63 patients with cirrhosis and hepatocellular carcinoma who were not suitable for surgery or transcatheter arterial chemoembolization (16). Most of the patients had mild to moderate local pain during or immediately after injection and 29% developed fever. [Pg.1286]

Kato T, Saito Y, Niwa M, Ishiguro J, Ogoshi K. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for imresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 1994 33(Suppl) S115-18. [Pg.1286]

Livraghi T. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Minimally Invasive Ther Allied Technol 1998 7 553-8. [Pg.1286]

Livraghi T, Benedini V, Lazzaroni S, Melon F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998 83(l) 48-57. [Pg.1286]

Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998 82(l) 78-85. [Pg.1286]

Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K. Hepatic infarction following percutaneous ethanol injection therapy for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1998 10(11) 915-18. [Pg.1286]

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 2002 37(3) 350-5. [Pg.1286]

Liao C, Yang K, Yen M, Teng L, Duffy S> Chen T. Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter... [Pg.1836]

Bartolozzi C et al. (1995) Treatment of large HCC transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197 812-8 Barton PP et al. (1996) Embolization of bone metastases. J Vase Intervent Radiol 7 81 8... [Pg.219]

Sella A et al. (1992) Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. J Urol 147 573 577 Shiina S et al. (1993) Percutaneous ethanol injection therapy for hepatocellular carcinoma resuhs in 146 patients. AJR Am J Roentgenol 160 1023 1028 Simonetti RG et al. (1991) Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36 962-972... [Pg.223]

Allgaier HP, Deibert P, Olschewski M, Spamer C, Blum U, Gerok W, Blum HE (1998) Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection-a single-center analysis including 132 patients. Int J Cancer 79 601-605... [Pg.58]

Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshi-kawa M, Kondo E, Saisho H (2005) Percutaneous ethanol injection for small hepatocellular carcinoma therapeutic efficacy based on 20-year observation. J Hepatol 43 458-464... [Pg.98]

Kim YJ, Raman SS, Yu NC, Eu DS (2005) MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2 T open MR system. J Magn Reson Imaging 22 566-571... [Pg.98]

Eee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW (1995) Percutaneous ethanol injection for the treatment of hepatic tumors indications, mechanism of action, technique, and efficacy. Am J Roentgenol 164 215-220... [Pg.98]

Eencioni R, Pinto F, ArmillottaN, Bassi AM, Moretti M, Di Giulio M, Marchi S, Uliana M, Della Capanna S, Lencioni M, Bartolozzi C (1997) Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis a European experience. Eur Radiol 7 514-519... [Pg.98]

Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut 54 1151-1156 Eivraghi T (1998) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 45 1248-1253 Eivraghi T, Giorgio A, Marin G, Salmi A, Sio I de, Bolondi... [Pg.98]

Percutaneous ethanol injection (PEI) is a well-tolerated and effective treatment in patients with HCC. PEI showed a high anti-tumoral efficacy in nodules smaller than 3 cm with a complete response rate in 80% (Bruix et al. 2001). Nevertheless, the high recurrence rate in patients with HCC after PEI, especially in those with high levels of AFP and those without peritumoral capsule or with large lesions and cirrhosis, decreases the long-term prognosis. [Pg.116]

Kirchhoff T, Chavan A, Galanski M (1998) Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma [comment]. Eur J Gastroenterol Hepatol 10 907-909 Kitamoto M, Imagawa M, Yamada H et al (2003) Radiofrequency ablation in the treatment of small hepatocellular carcinomas comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 181 997-1003... [Pg.120]

Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M (2002) Nonsurgical treatment of hepatocellular carcinoma from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62 64-68 Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation principles and applications. Radiographics 25 [Suppl 1] S69-S83... [Pg.121]

Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, De Sio 1, Brunello F, Solmi L, Caturelli E, Magnolfi F, Care-mani M, Filice C (1997) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multi-... [Pg.126]

Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, Chen PJ, Kao JH, Sheu JC (2005) Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma a prospective study. Ann Surg 242 36-42... [Pg.128]

Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H (2001) Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma a comparative study. Jpn J Clin Oncol 31 322-326... [Pg.128]

Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H (2001) Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma a randomized control study. Cancer 92 1516-1524... [Pg.128]

Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Miyauchi Y, Himoto T, Kimura Y, Nakai S, Deguchi A, Yoneyama H, Yoshida S, Kuriyama S (2005) Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 11 1426-1432... [Pg.128]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...